Aktis Oncology Inc
(AKTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTS | CRON | SPRY | ||
| Company | Aktis Oncology Inc | Cronos Group Inc | Ars Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 17.65 | 2.60 | 8.66 | ||
| High | 18.29 | 2.68 | 9.52 | ||
| Low | 17.65 | 2.58 | 8.66 | ||
| Latest | 18.00 | 2.68 | 9.40 | ||
| Change | +0.24 | +0.08 | +0.55 | ||
| % Change | +1.35% | +3.08% | +6.21% | ||
| Volume | 8,659 | 405,280 | 309,765 | ||
| 20-Day Average Volume | 259,893 | 1,373,769 | 1,284,311 | ||
| Previous Close | 17.76 | 2.60 | 8.85 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.83 | 2.62 | 9.98 | ||
| 20-Day Raw Stochastic | 22.71% | 62.60% | 38.33% | ||
| 20-Day Relative Strength | 38.74 | 51.98 | 44.94 | ||
| Weighted Alpha | N/A | +20.74 | -28.77 | ||
| Today's Opinion | N/A | 56% Buy | 72% Sell | ||
| Previous Opinion | N/A | 16% Buy | 72% Sell | ||
| Last Month's Opinion | N/A | 56% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.74% since 02/09/26 | +1.88% since 02/09/26 | -3.17% since 02/09/26 | ||
| Low | 16.80 on 02/11/26 | 2.57 on 02/12/26 | 8.61 on 02/13/26 | ||
| High | 19.30 on 02/10/26 | 2.74 on 02/10/26 | 10.11 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | -7.39% since 01/16/26 | +5.50% since 01/16/26 | -10.82% since 01/16/26 | ||
| Low | 16.80 on 02/11/26 | 2.40 on 02/02/26 | 8.61 on 02/13/26 | ||
| High | 23.36 on 01/22/26 | 2.83 on 01/23/26 | 10.88 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | N/A since 01/09/26 | +10.30% since 11/17/25 | +29.51% since 11/17/25 | ||
| Low | 16.80 on 02/11/26 | 2.28 on 11/21/25 | 6.66 on 11/21/25 | ||
| High | 29.16 on 01/09/26 | 3.43 on 12/15/25 | 13.15 on 01/12/26 | ||
| 6-Month | |||||
| %Chg | N/A since 01/09/26 | +12.62% since 08/15/25 | -34.76% since 08/15/25 | ||
| Low | 16.80 on 02/11/26 | 2.28 on 11/21/25 | 6.66 on 11/21/25 | ||
| High | 29.16 on 01/09/26 | 3.43 on 12/15/25 | 15.09 on 08/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 899,526 | 988,406 | 874,814 | ||
| Shares Outstanding, K | 50,649 | 380,156 | 98,849 | ||
| Annual Sales | 27,380,000 | 117,620,000 | 89,150,000 | ||
| Annual Net Income | -167,950,000 | 41,080,000 | 8,000,000 | ||
| Last Quarter Sales | 933,000 | 36,340,000 | 32,500,000 | ||
| Last Quarter Net Income | -12,056,000 | -6,570,000 | -51,150,000 | ||
| 60-Month Beta | N/A | 0.80 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.07 on 11/06/25 | -0.52 on 11/10/25 | ||
| Latest Earnings Date | 02/11/25 | 02/26/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||